V2V Blog

Can Your Brand Survive Without Paying Speakers?

V2V responds to the debate surrounding the ethics of speaker training.

 
Return of the Blockbusters? Who to Watch out for in 2014

V2V's ideas on which drugs have significant growth potential in 2014.

 
Speaker Portals: Cut Costs and Build Relationships

Amy Ravi discusses the future of KOL tracking and how it is expected to change in the coming year.

 
7 Things Really Amazing Speakers Do

Want to have the best speaker’s bureau? Your speakers will have to communicate effectively. Here are 7 practices to help them master.

 
The Early Impact of the Sunshine Act

Industry publications are flooded with articles trying to explain the Sunshine Act, but what is really happening as a result of the new legislation?

 
Why You May Not Be Targeting the Right KOLs

Peter Joshua of MMRG offers his insights on the importance of effective KOL audits

 
Three Reasons Live Speaker Training is a Good Option

How you can take charge of your work-life balance.

 
How to Select the Best Advisory Board Chair

Tips on how to pick the best Ad Board Chair

 
Getting More Out of Your Agency

How to get the most out of your medical education agency

 
Speaker Programs: Field-Driven vs. Marketing-Driven

Read about how conducting marketing-driven speaker programs provide 6 key advantages

 
Speakers and Consultants: The Big Data Revolution

Explaining the big data revolution of speakers and consultants

 
Four Reasons Why On-Demand Speaker Training Makes Sense

The reasons why On Demand Speaker Training can be very effective

 
Three Reasons DTC Marketing Will Likely Decline in 2013

Why DTC Marketing will Likely Decline in 2013

 
High Impact Advisory Boards Tips and Tricks

Some Tips and Tricks for High Impact Advisory Boards from Vision2Voice. -

 
Going Beyond Speaker Programs with Technology

How to use technology to connect with KOLs and physicians everywhere.

 
AMA Calls Obesity a Disease

The American Medical Association is trying to highlight the seriousness of obesity in America by calling obesity a disease.

 
U.S. Drug Market Shrinks

The U.S. drug market has shrunk for the first time. Read more here.